Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Companies Slated for Greatness in 2013 and Beyond: QUALCOMM, Inc. (QCOM), Covidien plc (COV) and More

Page 1 of 2

It’s February, and I’ve surprisingly managed to stick with my New Year’s resolution. Usually, by this point in time, my declaration serves o (NASDAQ:ORLY)nly as a painful reminder of my lack of willpower. And I’m not alone in my plan for transformation this year. In fact, many companies are getting into tip-top shape for 2013 and beyond. They’re making smart decisions now that’ll pave the way for greatness later.

Let’s take a look at five companies implementing fresh strategies or leveraging tried-and-true ideas.

QUALCOMM, Inc. (NASDAQ:QCOM)1. Starbucks Corporation (NASDAQ:SBUX) Despite a challenging global economic climate, Starbucks continues to kick tail and take names. The company recently unveiled plans for future growth, including expansion of its Verismo home-brewing coffee machines and drive-through locations. Starbucks’ Teavana tea, Evolution Fresh juice, and La Boulange bakery acquisitions are redefining and diversifying the company from its past coffee-shop-only status. And don’t discount the company’s enormous opportunities for international expansion. In fact, Starbucks is already enjoying success from its handful of recently opened stores in India.

2. Tesla Motors Inc (NASDAQ:TSLA) The Silicon Valley-based electric automaker is in the midst of a critical growth stage. The company recently turned cash flow positive, and CEO Elon Musk intends to make Tesla profitable for the first time by the end of the year. Tesla unveiled its highly anticipated crossover at the Detroit Auto Show. Sales of the Model X — which will go toe-to-toe with new luxury electric cars from BMW and Cadillac — will begin next year. Tesla is also working on a building a lower-priced model.

Last year Tesla announced its plans to expand its network of electric car recharging stations across the U.S. over the next several years. So far, it’s established a number of stations in California and along the East Coast. Converting solar energy to electricity, the stations allow Tesla customers to charge their cars for free. 

3. Covidien plc (NYSE:COV) This health care company boasts leading market positions across its product portfolio. Covidien operates three divisions — medical devices (which represents 68% of sales), pharmaceuticals (17% of sales), and medical supplies (15% of sales). The company will spin off its pharmaceutical business in mid-2013 and focus on the faster-growing, higher-margin medical device industry.

But, even with the divestment, Covidien will remain well diversified. The company plans to launch 100 new products across its portfolio by year-end 2014. It’s also enjoying strong sales growth in emerging markets. However, as a result of health care reform, two challenges for the company include pricing pressure and taxation on medical devices that went into effect at the start of 2013.

4. O’Reilly Automotive Inc (NASDAQ:ORLY) O’Reilly is the second-largest retailer of aftermarket parts, tools, and accessories for the auto industry. The company’s products are sold to both DIY customers and professional mechanics. This “dual-market strategy” diversifies revenues, maintains consistency, and acts as a competitive advantage for the company. Driven by stable growth in the auto parts market, O’Reilly has delivered 19 consecutive years of record revenues, earnings, and same-store sales growth since its 1993 IPO.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!